Dendrites cells activated by malignant stem cells antigens - technology of a new generation oncovaccine development

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Full Text

Restricted Access

About the authors

A. V. Bersenev

Author for correspondence.
Email: redaktor@celltranspl.ru
Russian Federation

References

  1. Banchereau J., Palucka A.K. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 2005; 5(4): 296-306.
  2. Nestle F.O., Farkas A., Conrad C. Dendritic-cell-based therapeutic vaccination against cancer. Curr. Opin. Immunol. 2005; 17(2): 163-9.
  3. Dalerba P., Cho R.W., Clarke M.F. Cancer Stem Cells: Model and Concepts. Annu. Rev. Med. 2007; 58: 18.1 -18.18.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1

Download (146KB)

Copyright (c) 2007 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies